CELG : Summary for Celgene Corporation - Yahoo Finance

U.S. Markets closed

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
113.62-1.60 (-1.39%)
At close: 4:00PM EST
People also watch
GILDBIIBREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close115.22
Open115.07
Bid113.62 x 200
Ask113.85 x 100
Day's Range113.15 - 115.29
52 Week Range93.05 - 127.00
Volume4,523,162
Avg. Volume4,967,716
Market Cap88.08B
Beta1.59
PE Ratio (TTM)43.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen
    Investor's Business Dailyyesterday

    Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

    Gilead will likely guide to declining 2017 sales, hamstrung on limited Hep C visibility, RBC said Wednesday.

  • Celgene Corp. – Value Analysis (NASDAQ:CELG) : January 18, 2017
    Capital Cubeyesterday

    Celgene Corp. – Value Analysis (NASDAQ:CELG) : January 18, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Celgene Corp. a score of 69. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson, Alexion Pharmaceuticals, Inc., Illumina, Inc., Epizyme, Inc. and ARIAD Pharmaceuticals, Inc. ... Read more (Read more...)

  • Benzingayesterday

    Orphan Drugs Among 2015's Top 10 Best-Selling Medications

    Orphan drugs , drugs intended to prevent, diagnose or treat rare diseases/disorders, are huge sellers for the pharmaceutical industry. NPR, citing data from EvaluatePharma, noted that seven of the 10 best-selling ...